首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1936954

全球腸外營養市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Parenteral Nutrition Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計腸外營養市場規模將從 2025 年的 87.4 億美元成長到 2034 年的 155.9 億美元，2026 年至 2034 年的複合年成長率為 6.65%。

由於慢性病發病率上升以及需要營養支持的患者數量不斷增加，腸外營養市場預計將迎來顯著成長。隨著醫療保健機構認知到合理營養對改善患者預後的重要性，對腸外營養解決方案的需求預計將會增加。該市場涵蓋多種產品，包括胺基酸、脂質、碳水化合物和維生素，旨在滿足經口進食困難患者的特定營養需求。人們對營養在復健和疾病管理中的作用認知不斷提高，正在推動腸外營養在各種醫療機構中的應用。

腸外營養製劑和輸注系統的創新也塑造著該市場的未來。針對個別患者需求（例如代謝狀況和合併症）的客製化營養解決方案的開發，正在提高腸外營養的有效性。此外，輸注技術的進步，包括智慧輸注幫浦和自動化系統，正在提高營養輸送的安全性和精確性，並降低腸外營養相關併發症的風險。隨著這些技術的不斷發展，預計市場產品種類將日益豐富，以滿足更廣泛的患者群體的需求。

此外，隨著醫療機構和製藥公司意識到營養支持方面尚未滿足的需求，加大研發投入將對腸外營養市場產生正面影響。臨床醫生、營養師和相關人員之間的合作對於推廣臨床指南和確保腸外營養的安全有效使用至關重要。在這種不斷變化的環境下，監管機構有望簡化創新配方的核准流程，並加速病患獲得救命營養療法的途徑。未來，人們將更加關注如何將腸外營養融入全面的患者照護策略，並強調營養在改善患者復原和整體健康方面的重要性。

區域分析
北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家

第9章競爭情勢

最新趨勢
公司分類
供應鏈和銷售管道合作夥伴（根據現有資訊）
市場佔有率和市場定位分析（基於現有資訊）
供應商格局（基於現有資訊）
策略規劃

第10章：公司簡介

主要公司的市佔率分析
公司簡介
- Baxter
- Grifols
- Allergan
- Otsuka Pharmaceutical Factory Inc
- Actavis Inc
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Vifor Pharma
- Sichuan Kelun Pharmaceutical Co. Ltd
- Pfizer Inc.（Hospira Inc.）

簡介目錄

Product Code: VMR11213929

The Parenteral Nutrition Market size is expected to reach USD 15.59 Billion in 2034 from USD 8.74 Billion (2025) growing at a CAGR of 6.65% during 2026-2034.

The parenteral nutrition market is set for significant growth, driven by the increasing prevalence of chronic diseases and the rising number of patients requiring nutritional support. As healthcare providers recognize the importance of adequate nutrition in improving patient outcomes, the demand for parenteral nutrition solutions is expected to rise. This market encompasses a range of products, including amino acids, lipids, carbohydrates, and vitamins, tailored to meet the specific nutritional needs of patients unable to consume food orally. The growing awareness of the role of nutrition in recovery and disease management is propelling the adoption of parenteral nutrition across various healthcare settings.

Innovations in parenteral nutrition formulations and delivery systems are also shaping the future of this market. The development of customized nutrition solutions that consider individual patient requirements, such as metabolic conditions and comorbidities, is enhancing the effectiveness of parenteral nutrition. Additionally, advancements in infusion technology, including smart pumps and automated systems, are improving the safety and accuracy of nutrient delivery, reducing the risk of complications associated with parenteral feeding. As these technologies continue to evolve, the market is likely to witness a diversification of product offerings that cater to a wide range of patient populations.

Furthermore, the parenteral nutrition market will benefit from increased investment in research and development, as healthcare organizations and pharmaceutical companies recognize the unmet needs in nutritional support. Collaborative efforts between clinicians, nutritionists, and industry stakeholders will be crucial in advancing clinical guidelines and ensuring the safe and effective use of parenteral nutrition. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative formulations, facilitating faster access to life-saving nutritional therapies. The focus will increasingly shift towards integrating parenteral nutrition into comprehensive patient care strategies, emphasizing the importance of nutrition in enhancing recovery and overall health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Nutrient Type

Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

By A Stage Type

Adult
Pediatrics

By Indication

Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
ByA Sales Channel
Online
Retail
Institutional

COMPANIES PROFILED

Baxter, Grifols, Allergan, Otsuka Pharmaceutical Factory Inc, Actavis Inc, B Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co Ltd, Pfizer Inc Hospira Inc

We can customise the report as per your requriements

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PARENTERAL NUTRITION MARKET: BY NUTRIENT TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Nutrient Type
4.2. Carbohydrates Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Parenteral Lipid Emulsion Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Single Dose Amino Acid Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Trace Elements Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Vitamins & Minerals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PARENTERAL NUTRITION MARKET: BY STAGE TYPE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Stage Type
5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Pediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PARENTERAL NUTRITION MARKET: BY INDICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Indication
6.2. Alzheimer's Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Nutrition Deficiency Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Cancer Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Chronic Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.7. Orphan Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.8. Dysphagia Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.9. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.10. Malabsorption/GI Disorder/Diarrhea Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PARENTERAL NUTRITION MARKET: BY SALES CHANNEL 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Sales Channel
7.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Retail Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Institutional Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PARENTERAL NUTRITION MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Nutrient Type
- 8.2.2 By Stage Type
- 8.2.3 By Indication
- 8.2.4 By Sales Channel
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Nutrient Type
- 8.3.2 By Stage Type
- 8.3.3 By Indication
- 8.3.4 By Sales Channel
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Nutrient Type
- 8.4.2 By Stage Type
- 8.4.3 By Indication
- 8.4.4 By Sales Channel
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Nutrient Type
- 8.5.2 By Stage Type
- 8.5.3 By Indication
- 8.5.4 By Sales Channel
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Nutrient Type
- 8.6.2 By Stage Type
- 8.6.3 By Indication
- 8.6.4 By Sales Channel
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PARENTERAL NUTRITION INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Baxter
- 10.2.2 Grifols
- 10.2.3 Allergan
- 10.2.4 Otsuka Pharmaceutical Factory Inc
- 10.2.5 Actavis Inc
- 10.2.6 B. Braun Melsungen AG
- 10.2.7 Fresenius Kabi AG
- 10.2.8 Vifor Pharma
- 10.2.9 Sichuan Kelun Pharmaceutical Co. Ltd
- 10.2.10 Pfizer Inc. (Hospira Inc.)